Innosys Valuation
Is A056090 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of A056090 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate A056090's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate A056090's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for A056090?
Key metric: As A056090 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is A056090's PE Ratio? | |
|---|---|
| PE Ratio | 59.9x |
| Earnings | ₩1.98b |
| Market Cap | ₩119.78b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 2.7x |
| Enterprise Value/EBITDA | 22.6x |
| PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does A056090's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 21.4x | ||
A228850 Rayence | 9.2x | 20.7% | ₩102.4b |
A302550 RemedLtd | 24.4x | n/a | ₩119.3b |
A208370 SELVAS Healthcare | 31.5x | n/a | ₩121.5b |
A004080 Shinhung | 20.4x | n/a | ₩135.0b |
A056090 Innosys | 59.9x | n/a | ₩119.8b |
Price-To-Earnings vs Peers: A056090 is expensive based on its Price-To-Earnings Ratio (59.9x) compared to the peer average (21.4x).
Price to Earnings Ratio vs Industry
How does A056090's PE Ratio compare vs other companies in the KR Medical Equipment Industry?
| 1 Company | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
A035610 Solborn | 2.6x | n/a | US$67.90m |
| 1 Company | Estimated Growth | Market Cap |
|---|
Price-To-Earnings vs Industry: A056090 is expensive based on its Price-To-Earnings Ratio (59.9x) compared to the KR Medical Equipment industry average (12.2x).
Price to Earnings Ratio vs Fair Ratio
What is A056090's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 59.9x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate A056090's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Boditech Med
₩347.2b
Offers instruments and diagnostic reagents in South Korea and internationally.
A206640
₩15,760.00
7D
-2.1%
1Y
-12.9%
Vieworks
₩200.2b
Develops, manufactures, and sells imaging systems and solutions.
A100120
₩21,000.00
7D
3.4%
1Y
-24.2%
Access Bio
₩188.3b
Engages in the research, development, and manufacture of in vitro rapid diagnostic tests, biosensors, and molecular diagnostic products worldwide.
A950130
₩5,570.00
7D
2.0%
1Y
-37.1%